Tuesday, April 21, 2026

Osstem Implant Highlights Global Influence Through International Academic Event

Osstem Implant's "World Meeting 2026" showcased digital dentistry advancements with 1,200 global attendees, celebrating 10 years of innovation.

How NVIDIA is Fueling a Surge in Crypto Markets!

The AI fever ignited by American semiconductor company Nvidia fuels excitement in the cryptocurrency market.

YG Plus Shares Drop 11% After Rosé’s “APT.” Success Boosted Stock

YG Plus stock dropped 11% on Tuesday, following a surge from Rosé's "APT." Poor earnings and profit-taking contributed to the decline.

Tag: antibody-drug conjugate

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

Top News

- Our Sponsors Ad -

Follow us